| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADD3
|
adducin 3 (gamma)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
ATF2
|
activating transcription factor 2
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CARD9
|
caspase recruitment domain family, member 9
|
|
CASR
|
calcium-sensing receptor
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CLDN7
|
claudin 7
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTTN
|
cortactin
|
|
CUL5
|
cullin 5
|
|
CUX1
|
cut-like homeobox 1
|
|
DGKA
|
diacylglycerol kinase, alpha 80kDa
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EPHB2
|
EPH receptor B2
|
|
FLCN
|
folliculin
|
|
FOXO1
|
forkhead box O1
|
|
GDPD5
|
glycerophosphodiester phosphodiesterase domain containing 5
|
|
GLIS2
|
GLIS family zinc finger 2
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
H2AFX
|
H2A histone family, member X
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HIST1H2BB
|
histone cluster 1, H2bb
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HIST2H3C
|
histone cluster 2, H3c
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
ILK
|
integrin-linked kinase
|
|
INSR
|
insulin receptor
|
|
IRS1
|
insulin receptor substrate 1
|
|
JUN
|
jun proto-oncogene
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
|
KCNJ13
|
potassium channel, inwardly rectifying subfamily J, member 13
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KDR
|
kinase insert domain receptor
|
|
KSR1
|
kinase suppressor of ras 1
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPHP1
|
nephronophthisis 1 (juvenile)
|
|
OXSR1
|
oxidative stress responsive 1
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKCD
|
protein kinase C, delta
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PXN
|
paxillin
|
|
RB1
|
retinoblastoma 1
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC14A2
|
solute carrier family 14 (urea transporter), member 2
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLK
|
STE20-like kinase
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SPTAN1
|
spectrin, alpha, non-erythrocytic 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK39
|
serine threonine kinase 39
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TFEB
|
transcription factor EB
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TP53
|
tumor protein p53
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
TSC2
|
tuberous sclerosis 2
|
|
UBTF
|
upstream binding transcription factor, RNA polymerase I
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
